Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1980 Sep;32(5):670–680.

Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients.

F Y Choy, R G Davidson
PMCID: PMC1686089  PMID: 6775530

Abstract

A reproducible and convenient method for assaying glucocerebrosidase activity using the natural substrates has been developed. From the insoluble pellet fraction of cultured skin fibroblast homogenates, released glucose was measured enzymically using hexokinase coupled with the glucose-6-phosphate dehydrogenase (G6PD) and nicotinamide adenine dinucleotide phosphate (NADP) system. Optimal enzyme assay conditions required both Triton X-100 and sodium taurocholate, pH 4.8. Glucocerebrosidase activities from three patients with type 1 Gaucher disease were 17.5%, 15.8%, and 11.2% of normal (normal = 198 +/- 14 nmol/hr per mg protein, n = 3). The first patient had normal beta-glucosidase activity with the artificial fluorogenic umbelliferone substrate. Interference with the accuracy of the glucose-dependent assay system by either glycolytic or gluconeogenic enzyme activites was not detected under these experimental conditions, and when substrates with long fatty-acid chain lengths (C = 22) were used, markedly decreased glucocerebrosidase activity occurred in both normal individuals and patients. The apparent Km's for the natural substrates were 0.56 +/- 0.05 mM for controls and 2.2-3.3 mM for Gaucher fibroblasts. These data further support the hypothesis that a structurally altered and catalytically deficient enzyme is synthesized in patients with type 1 Gaucher disease and illustrate the value of the natural substrate in investigating patients.

Full text

PDF
673

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTHELMAI W., CZOK R. [Enzymatic determinations of glucose in the blood, cerebrospinal fluid and urine]. Klin Wochenschr. 1962 Jun 1;40:585–589. doi: 10.1007/BF01478633. [DOI] [PubMed] [Google Scholar]
  2. BRADY R. O., KANFER J. N., SHAPIRO D. METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE. Biochem Biophys Res Commun. 1965 Jan 18;18:221–225. doi: 10.1016/0006-291x(65)90743-6. [DOI] [PubMed] [Google Scholar]
  3. Barton N. W., Rosenberg A. Metabolism of glucosyl [13H]ceramide by human skin fibroblasts from normal and glucosylceramidotic subjects. J Biol Chem. 1975 May 25;250(10):3966–3971. [PubMed] [Google Scholar]
  4. Ben-Yoseph Y., Nadler H. L. Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease. J Clin Pathol. 1978 Nov;31(11):1091–1093. doi: 10.1136/jcp.31.11.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beutler E., Kuhl W. The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes. J Lab Clin Med. 1970 Nov;76(5):747–755. [PubMed] [Google Scholar]
  6. Beutler E., Kuhl W., Trinidad F., Teplitz R., Nadler H. Beta-glucosidase activity in fibroblasts from homozygotes and heterozygotes for Gaucher's disease. Am J Hum Genet. 1971 Jan;23(1):62–66. [PMC free article] [PubMed] [Google Scholar]
  7. Broadhead D. M., Butterworth J. The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside. Clin Chim Acta. 1977 Feb 15;75(1):155–161. doi: 10.1016/0009-8981(77)90512-5. [DOI] [PubMed] [Google Scholar]
  8. Chiao Y. B., Hoyson G. M., Peters S. P., Lee R. E., Diven W., Murphy J. V., Glew R. H. Multiple glycosidase deficiencies in a case of juvenile (type 3) Gaucher disease. Proc Natl Acad Sci U S A. 1978 May;75(5):2448–2452. doi: 10.1073/pnas.75.5.2448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Choy F. Y., Davidson R. G. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues. Pediatr Res. 1980 Jan;14(1):54–59. doi: 10.1203/00006450-198001000-00013. [DOI] [PubMed] [Google Scholar]
  10. Choy F. Y., Davidson R. G. Gaucher's disease. I. Solubilization and electrophoresis of beta-glucosidase from leukocytes and cultured fibroblasts. Pediatr Res. 1978 Dec;12(12):1115–1120. doi: 10.1203/00006450-197812000-00003. [DOI] [PubMed] [Google Scholar]
  11. Ho M. W. Identity of 'acid' beta-glucosidase and glucocerebrosidase in human spleen. Biochem J. 1973 Nov;136(3):721–729. doi: 10.1042/bj1360721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ho M. W., O'Brien J. S. Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro. Proc Natl Acad Sci U S A. 1971 Nov;68(11):2810–2813. doi: 10.1073/pnas.68.11.2810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ho M. W., Seck J., Schmidt D., Veath M. L., Johnson W., Brady R. O., O'Brien J. S. Adult Gaucher's disease: kindred studies and demonstration of a deficiency of acid beta-glucosidase in cultured fibroblasts. Am J Hum Genet. 1972 Jan;24(1):37–45. [PMC free article] [PubMed] [Google Scholar]
  14. Hyun J. C., Misra R. S., Greenblatt D., Radin N. S. Synthetic inhibitors of glucocerebroside beta-glucosidase. Arch Biochem Biophys. 1975 Feb;166(2):382–389. doi: 10.1016/0003-9861(75)90401-4. [DOI] [PubMed] [Google Scholar]
  15. Klibansky C., Hoffman J., Zaizov R., Matoth Y. Gaucher's disease, chronic adult type: a comparative study of glucocerebroside and methylumbelliferyl-glucopyranoside cleaving potency in leukocytes. Biomedicine. 1974 Jan;20(1):24–30. [PubMed] [Google Scholar]
  16. Koerner T. A., Jr, Cary L. W., Li S. C., Li Y. T. Carbon 13 NMR spectroscopy of a cerebroside. Proof of the beta-pyranosyl structure of D-glucosylceramide. J Biol Chem. 1979 Apr 10;254(7):2326–2328. [PubMed] [Google Scholar]
  17. Kuske T. T., Rosenberg A. Quantity and fatty acyl composition of the glycosphingolipids of Gaucher spleen. J Lab Clin Med. 1972 Oct;80(4):523–529. [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. Mueller O. T., Rosenberg A. Activation of membrane-bound glucosylceramide: beta-glucosidase in fibroblasts cultured from normal and glucosylceramidotic human skin. J Biol Chem. 1979 May 10;254(9):3521–3525. [PubMed] [Google Scholar]
  20. Mueller O. T., Rosenberg A. beta-Glucoside hydrolase activity of normal and glucosylceramidotic cultured human skin fibroblasts. J Biol Chem. 1977 Feb 10;252(3):825–829. [PubMed] [Google Scholar]
  21. Ockerman P. A. Identity of beta-glucosidase, beta-xylosidase and one of the beta-galactosidase activities in human liver when assayed with 4-methylumbelliferyl-beta-D-glycosides studies in cases of Gaucher's disease. Biochim Biophys Acta. 1968 Aug 6;165(1):59–62. [PubMed] [Google Scholar]
  22. Owada M., Sakiyama T., Kitagawa T. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver. Pediatr Res. 1977 May;11(5):641–646. doi: 10.1203/00006450-197705000-00004. [DOI] [PubMed] [Google Scholar]
  23. Pentchev P. G., Brady R. O., Blair H. E., Britton D. E., Sorrell S. H. Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3970–3973. doi: 10.1073/pnas.75.8.3970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pentchev P. G., Brady R. O., Hibbert S. R., Gal A. E., Shapiro D. Isolation and characterization of glucocerebrosidase from human placental tissue. J Biol Chem. 1973 Aug 10;248(15):5256–5261. [PubMed] [Google Scholar]
  25. Peters S. P., Coyle P., Glew R. H. Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate. Arch Biochem Biophys. 1976 Aug;175(2):569–582. doi: 10.1016/0003-9861(76)90547-6. [DOI] [PubMed] [Google Scholar]
  26. Peters S. P., Lee R. E., Glew R. H. A microassay for Gaucher's disease. Clin Chim Acta. 1975 May 1;60(3):391–396. doi: 10.1016/0009-8981(75)90083-2. [DOI] [PubMed] [Google Scholar]
  27. ROSENBERG A., CHARGAFF E. A reinvestigation of the cerebroside deposited in Gaucher's disease. J Biol Chem. 1958 Dec;233(6):1323–1326. [PubMed] [Google Scholar]
  28. SUOMI W. D., AGRANOFF B. W. LIPIDS OF THE SPLEEN IN GAUCHER'S DISEASE. J Lipid Res. 1965 Apr;6:211–219. [PubMed] [Google Scholar]
  29. Turner B. M., Beratis N. G., Hirschhorn K. Cell-specific differences in membrane beta-glucosidase from normal and Gaucher cells. Biochim Biophys Acta. 1977 Feb 9;480(2):442–449. doi: 10.1016/0005-2744(77)90036-5. [DOI] [PubMed] [Google Scholar]
  30. Wenger D. A., Clark C., Sattler M., Wharton C. Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease. Clin Genet. 1978 Feb;13(2):145–153. doi: 10.1111/j.1399-0004.1978.tb04242.x. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES